XASX
NOU
Market cap19mUSD
Jul 10, Last price
0.11AUD
1D
0.00%
1Q
0.00%
Jan 2017
-97.49%
Name
Noumi Ltd
Chart & Performance
P/E
—
P/S
0.05
EPS
—
Div Yield, %
—
Shrs. gr., 5y
0.20%
Rev. gr., 5y
0.53%
Revenues
596m
+1.03%
Net income
-150m
L+52.55%
CFO
33m
+105.41%
Dividend
Nov 01, 20190.05004382 AUD/sh
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Noumi Limited operates as a comprehensive food and beverage enterprise, handling everything from ingredient procurement and manufacturing to the marketing, sales, and distribution of its products for both wholesale and retail customers. The company's business is segmented into Dairy and Nutritional offerings, and Plant-Based Beverages. Its dairy and nutritional portfolio includes a variety of ultra-heat treated (UHT) shelf-stable milk beverages, alongside performance and adult nutritional powders and other dietary supplements. In its plant-based division, Noumi produces an extensive range of UHT shelf-stable food and drink options, such as almond, oat, soy, rice, coconut, hazelnut, and other nut-based milks, as well as liquid cooking stocks. These diverse products are sold under well-known brands including Milklab, Australia's Own, Crankt, Vital Strength, Noumi Nutritionals, Uproteinn, So Natural, and Vitalife. The company has a broad international footprint, with operations spanning Australia, New Zealand, South Africa, China, Southeast Asia, and the Middle East. Established in 1984, the entity formerly known as Freedom Foods Group Limited is headquartered in Ingleburn, Australia, and functions as a subsidiary of Arrovest Pty Limited.
Valuation
Title AUD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|
| 2025‑06 | 2024‑06 | 2023‑06 | 2022‑06 | 2021‑06 | 2020‑06 | 2019‑06 | 2018‑06 | 2017‑06 | |
| Income | |||||||||
Revenues | |||||||||
Cost of revenue | |||||||||
Unusual Expense (Income) | |||||||||
NOPBT | |||||||||
NOPBT Margin | |||||||||
Operating Taxes | |||||||||
Tax Rate | |||||||||
NOPAT | |||||||||
Net income | |||||||||
Dividends | |||||||||
Dividend yield | |||||||||
Proceeds from repurchase of equity | |||||||||
BB yield | |||||||||
| Debt | |||||||||
Debt current | |||||||||
Long-term debt | |||||||||
Deferred revenue | |||||||||
Other long-term liabilities | |||||||||
Net debt | |||||||||
| Cash flow | |||||||||
Cash from operating activities | |||||||||
CAPEX | |||||||||
Cash from investing activities | |||||||||
Cash from financing activities | |||||||||
FCF | |||||||||
| Balance | |||||||||
Cash | |||||||||
Long term investments | |||||||||
Excess cash | |||||||||
Stockholders' equity | |||||||||
Invested Capital | |||||||||
ROIC | |||||||||
ROCE | |||||||||
| EV | |||||||||
Common stock shares outstanding | |||||||||
Price | |||||||||
Market cap | |||||||||
EV | |||||||||
EBITDA | |||||||||
EV/EBITDA | |||||||||
Interest | |||||||||
Interest/NOPBT | |||||||||